Answers are grounded in this paper and cite their sources.
Background Mesenchymal stem cells (MSCs) have the potential to treat Alzheimer’s disease (AD), but their therapeutic efficacy is limited by apoptosis and other complications during in vitro culture. Tanshinone IIA (Tan IIA), a major lipophilic diterpenoid quinone derived from the traditional Chinese medicine Salvia miltiorrhiza , exhibits antioxidant and anti-inflammatory activities and has been reported to enhance MSC functionality. Objective This study aimed to investigate whether Tan IIA preconditioning optimizes MSC function to enhance therapeutic efficacy in AD models, and to elucidate the underlying molecular mechanisms. Methods Mouse bone marrow-derived MSCs were preconditioned with 12 μM Tan IIA for 48 h (termed TIIA-MSCs). In vitro assessments included cell proliferation (CCK-8), apoptosis, stemness marker expression, and transcriptomic analysis. TIIA-MSCs or unmodified MSCs (5 × 10 5 cells) were transplanted into 6- to 7-month-old 3 × Tg-AD mice via tail vein injection. Cognitive function was evaluated using the Y-maze, novel object recognition, and Morris water maze tests. Additionally, hippocampal neuronal damage, synaptic ultrastructure, Aβ42 levels, and apoptosis-related protein expression were examined via histology, immunofluorescence, transmission electron microscopy, and Western blotting. Results Tan IIA preconditioning significantly promoted MSC proliferation, reduced apoptosis, maintained stemness (Nanog/Oct4), and activated the PI3K/AKT signaling pathway. In the 3 × Tg-AD mouse model, TIIA-MSC transplantation more effectively ameliorated learning and memory deficits, attenuated hippocampal neuronal loss, protected synaptic ultrastructure, and upregulated PSD-95 expression compared with unmodified MSCs. Mechanistically, TIIA-MSCs reduced Aβ42 levels, elevated the Bcl-2/Bax ratio, reduced total cytochrome c levels, and inhibited subsequent Caspase-3/PARP pathway activation in the brain. Conclusion Tan IIA preconditioning optimizes MSC functions associated with PI3K/AKT activation and enhances their neuroprotective efficacy against AD-related apoptosis.
No takes yet. Share an insight, caveat, or question.
Ge et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: